personalized medicine
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.
Insights into personalized genomics can help prevent diseases in outer space.
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.
Kaiser Permanente CEO Bernard Tyson believes three major trends are driving changes in the healthcare system, he said during his keynote on the final day of the Health 2.
What patient generated data used to be and why it is increasingly important
Dr.